Skip to main content
SpringerLink
Log in

Does Influenza Vaccination Exacerbate Asthma?

  • Current Opinion
  • Published:
Drug Safety Aims and scope Submit manuscript

Abstract

A few anecdotal reports have described serious asthma exacerbations following influenza vaccination. However, a causal relationship has not been clearly established since the vaccine is administered at the time of year when the background incidence of asthma exacerbation is high. Some reports describing minor pulmonary function changes or increased bronchial reactivity in patients with asthma receiving influenza vaccination did not include placebo controls and the results as they are reported are difficult to interpret. Results from several placebocontrolled studies, open trials, and US and European postmarketing surveillance data have shown no evidence of asthma exacerbation related to killed influenza vaccination, although 1 recent placebo-controlled study demonstrated a decrease in peak flow in a small number of first-time vaccinees without clinical exacerbation of asthma. A recent report demonstrated that a group of children with acute asthma exacerbation tolerated influenza vaccination to the same degree as patients with stable asthma. Thus, a plethora of evidence indicates that killed-sub-unit influenza vaccination is well tolerated and does not exacerbate asthma to a clinically significant degree. Limited experience with live influenza vaccine also suggests that it may be safely given to patients with asthma. Although vaccine efficacy has not been unequivocally demonstrated in patients with asthma, the potential benefits from prevention of morbidity associated with influenza infection in these patients outweighs the theoretical concerns over the safety of influenza vaccination.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Rothbarth PH, Kempen BM, Sprenger JW. Sense and nonsense of influenza vaccination in asthma and chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1995; 151: 1682–6

    PubMed  CAS  Google Scholar 

  2. Glezen WP. Serious morbidity and mortality associated with influenza epidemics. Epidemiol Rev 1982; 4: 25–44

    PubMed  CAS  Google Scholar 

  3. Minor TE, Dick EC, Baker JW, et al. Rhinovirus and influenza type A infections as precipitants of asthma. Am Rev Respir Dis 1976; 113: 149–53

    PubMed  CAS  Google Scholar 

  4. Nicholson KG, Kent J, Ireland DC. Respiratory virus and exacerbations of asthma in adults. BMJ 1993; 307: 982–6

    Article  PubMed  CAS  Google Scholar 

  5. Committee on Infectious Diseases. Influenza. In: 1997 Red Book. Elk Grove Village (IL); American Academy of Pediatrics, 1997: 310–4

    Google Scholar 

  6. Centers for Disease Control. Immunization Practices Advisory Committee (ACIP): prevention and control of influenza. MMWR Morb Mortal Wkly Rep 1997; 46: 1–25

    Google Scholar 

  7. Guidelines for the diagnosis and management of asthma. National Heart, Lung and Blood Institute. National Asthma Education Program. Expert Panel Report 2. 1997

  8. Wiselka MJ, Kent J, Nicholson KG, et al. Influenza and asthma. Lancet 1992; 339: 367–8

    Article  PubMed  CAS  Google Scholar 

  9. Gross PA, Quinnan GV, Rodstein M, et al. Association of influenza immunization with reduction in mortality in an elderly population. A prospective study. Arch Intern Med 1988; 148: 562–5

    Article  PubMed  CAS  Google Scholar 

  10. Barker WH, Mullooly JP. Influenza vaccination of elderly persons: reduction in pneumonia and influenza hospitalizations and deaths. JAMA 1980; 244: 2547–9

    Article  PubMed  CAS  Google Scholar 

  11. Sugiura A, Yanagawa H, Enomoto C, et al. A field trial for evaluation of the prophylactic effect of influenza vaccine containing inactivated A1/Hong Kong and B influenza viruses. J Infect Dis 1978; 122: 472–8

    Article  Google Scholar 

  12. Meiklejohn G, Eickhoff TC, Graves P, et al. Antigenic drift and efficacy of influenza virus vaccines, 1976–1977. J Infect Dis 1978; 138: 618–24

    Article  PubMed  CAS  Google Scholar 

  13. Sugaya N, Nerome K, Ishida M, et al. Efficacy of inactivated vaccine in preventing antigenically drifted influenza type A and well-matched type B. JAMA 1994; 272: 1122–6

    Article  PubMed  CAS  Google Scholar 

  14. Szilagyi PG, Rodewald LE, Wavageau J, et al. Improving influenza vaccination rates in children with asthma: a test of a computerized reminder system and an analysis of factors predicting vaccination compliance. Pediatrics 1992; 90: 871–5

    PubMed  CAS  Google Scholar 

  15. Hall CB. Influenza: a shot or not? Pediatrics 1987; 79: 564–6

    PubMed  CAS  Google Scholar 

  16. Gross P. Reactogenicity and immunogenicity of bivalent influenza vaccine in one- and two-dose trials in children. J Infect Dis 1977; 136 Suppl.: S616–25

    Article  PubMed  Google Scholar 

  17. Margolis KL, Nichol KL, Poland GA. Frequency of adverse reactions to influenza vaccine in the elderly. A randomized, placebo-controlled trial. JAMA 1990; 264: 1139–41

    Article  PubMed  CAS  Google Scholar 

  18. Busse WW. The contribution of viral respiratory infections to the pathogenesis of airway hyperreactivity. Chest 1993; 93: 1076–82

    Article  Google Scholar 

  19. Empey DW, Laitinen LA, Jacobs L, et al. Mechanisms of bronchial hyperreactivity in normal subjects after upper respiratory tract infection. Am Rev Respr Dis 1976; 113: 131–9

    CAS  Google Scholar 

  20. Welliver RC, Wong DT, Sun E, et al. The development of respiratory syncytial virus-specific IgE and the release of histamine in nasopharyngeal secretions after infection. N Engl J Med 1981; 305: 841–6

    Article  PubMed  CAS  Google Scholar 

  21. Busse WW, Swenson CA, Borden EC, et al. Effect of influenza A virus on leukocyte histamine release. J Allergy Clin Immunol 1983; 71: 382–8

    Article  PubMed  CAS  Google Scholar 

  22. Busse WW, Vrtis RF, Steiner R. In vitro incubation with influenza virus primes human polymorphonuclear leukocyte generation of superoxide. Am J Respir Cell Mol Biol 1991; 4: 347–54

    PubMed  CAS  Google Scholar 

  23. Hassan WU, Henderson AF, Keaney NP. Influenza vaccination in asthma [letter]. Lancet 1992; 339(8786): 194

    Article  PubMed  CAS  Google Scholar 

  24. Daggett P. Influenza and asthma [letter]. Lancet 1992; 339(8789): 367

    Article  PubMed  CAS  Google Scholar 

  25. Nicholson KG, Nguyen-Van-Tam JS, Ahmed AH, et al. Randomized placebo-controlled crossover trial on effect of inactivated influenza vaccine on pulmonary function in asthma. Lancet 1998; 351: 326–31

    Article  PubMed  CAS  Google Scholar 

  26. Ouellette JJ, Reed CE. Increased response of asthmatic subjects to methacholine after influenza vaccine. J Allergy 1965; 36: 558–63

    Article  PubMed  CAS  Google Scholar 

  27. Bell TD, Chai H, Berlow B, et al. Immunization with killed influenza virus in children with chronic asthma. Chest 1978; 73: 140–5

    Article  PubMed  CAS  Google Scholar 

  28. Banks J, Bevan C, Fennerty A, et al. Association between rise in antibodies and increase in airway sensitivity after intramuscular injection of killed influenza virus in asthmatic patients. Eur J Respir Dis 1985; 66: 268–72

    PubMed  CAS  Google Scholar 

  29. Albazzaz MK, Harvey JE, Grilli EA, et al. Subunit influenza vaccination in adults wtih asthma: effect on clinical state, airway reactivity, and antibody response. BMJ 1987; 294: 1196–7

    Article  PubMed  CAS  Google Scholar 

  30. DeJongste JC, Degenhart HJ, Neijens HJ, et al. Bronchial responsiveness and leucocyte reactivity after influenza vaccine in asthmatic patients. Eur J Respir Dis 1984; 65: 196–200

    CAS  Google Scholar 

  31. Ghirga G, Ghirg P, Rodino P, et al. Safety of the subunit influenza vaccine in asthmatic children. Vaccine 1991; 9: 913–4

    Article  PubMed  CAS  Google Scholar 

  32. Kava T, Lindqvist A, Karjalainen J, et al. Unchanged bronchial reactivity after killed influenza virus vaccine in adult asthmatics. Respiration 1987; 51: 98–104

    Article  PubMed  CAS  Google Scholar 

  33. Stenius-Aarniala B, Huttunen JK, Pyhala R, et al. Lack of clinical exacerbations in adults with chronic asthma after immunization with killed influenza virus. Chest 1986; 89: 786–9

    Article  PubMed  CAS  Google Scholar 

  34. Retailliau HF, Curtis AC, Storr G, et al. Illness after influenza vaccination reported through a nationwide surveillance system, 1976–1977. Am J Epidemiol 1980; 111: 270–8

    PubMed  CAS  Google Scholar 

  35. Watson JM, Cordier JF, Nicholson KG. Does influenza immunisation cause exacerbations of chronic airflow obstruction or asthma? Thorax 1997; 52: 190–4

    Article  PubMed  CAS  Google Scholar 

  36. Palache AM, vd Velden JW. Influenza vaccination in asthma [letter]. Lancet 1992; 339: 741

    Article  PubMed  CAS  Google Scholar 

  37. Park CL, Frank AL, Sullivan M, et al. Influenza vaccination of children during acute asthma exacerbation and concurrent prednisone therapy. Pediatrics 1996; 98: 196–200

    PubMed  CAS  Google Scholar 

  38. Edwards KM, King JC, Steinhoff MC, et al. Safety and immunogenicity of live attenuated cold-adapted influenza B/Ann Arbor/1/86 reassortant virus vaccine in infants and children. J Infect Dis 1991; 163: 740–5

    Article  PubMed  CAS  Google Scholar 

  39. Atmar RL, Bloom K, Keitel W, et al. Effect of live attenuated, cold recombinant (CR) influenza virus vaccines on pulmonary function in healthy and asthmatic adults. Vaccine 1990; 8: 217–24

    Article  PubMed  CAS  Google Scholar 

  40. Tanaka Y, Ueda K, Miyazaki C, et al. Trivalent cold recombinant influenza live vaccine in institutionalized children with bronchial asthma and patients with psychomotor retardation. Pediatr Infect Dis J 1993; 12: 600–5

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Paediatrics, Asthma and Allergy Center, University of Illinois at Chicago, 840 S. Wood Street, Chicago, Illinois, IL 60612, USA

    C. Lucy Park & Arthur Frank

Authors
  1. C. Lucy Park
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Arthur Frank
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to C. Lucy Park.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Park, C.L., Frank, A. Does Influenza Vaccination Exacerbate Asthma?. Drug-Safety 19, 83–88 (1998). https://doi.org/10.2165/00002018-199819020-00001

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00002018-199819020-00001

Keywords

Search

Navigation